Abstract
Background: There is a paucity of reports evaluating the perioperative risk of noncardiac surgery in patients with hypertrophic cardiomyopathy (HCM).
Hypothesis: The study was undertaken to evaluate the incidence of acute myocardial infarction (MI) and all‐cause in‐hospital mortality following noncardiac surgery in patients with HCM.
Methods: We searched the National Hospital Discharge Survey database for patients with a diagnosis of HCM who had undergone noncardiac surgery. Cases were matched by age, gender, and year of surgery. Death or acute MI were used as endpoints for analysis.
Results: From 1996 to 2002, 227 patients with HCM were matched with 554 controls (representing national estimates of 25,874 HCM and 50,326 controls patients). Patients with HCM were more likely than controls to have a history of atrial fibrillation (22.7 vs. 10.6%, p < 0.001) and of congestive heart failure (CHF) (24.2 vs. 14.1%, p < 0.001). The in‐hospital incidence of death or MI was higher in patients with HCM than in controls (6.7 vs. 2.5%, p < 0.001 for death and 2.2 vs. 0.3%, p<0.001forMI). After correcting for age, gender, race, presence of hypertension, diabetes mellitus, history of coronary artery‐disease, history of CHF, atrial fibrillation, and ventricular arrhythmias in a multivariate binary logistic regression model, the presence of HCM increased the odds of death by 61% (odds ratio [OR] = 1.61, 95% confidence interval [CI] 1.46–1.77, p < 0.001), and almost tripled the odds of the combined endpoint of death or MI (OR = 2.82,95% CI 2.59–3.07, p< 0.001).
Conclusion: The presence of HCM significantly increases the risk of death and MI associated with noncardiac surgery. Patients with HCM undergoing elective procedures may require more careful preoperative assessment and perioperative monitoring. The impact of the severity of HCM on outcomes of noncardiac surgery needs further study.
Keywords: hypertrophic cardiomyopathy, noncardiac surgery, death, myocardial infarction
Full Text
The Full Text of this article is available as a PDF (29.6 KB).
References
- 1. Nishimura RA, Holmes DR Jr: Hypertrophic obstructive cardiomyopathy. N Engl J Med 2004; 350: 1320–1327 [DOI] [PubMed] [Google Scholar]
- 2. Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Mark Estes NA III, Araújo CGS, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP, for the Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young : Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004; 109: 2807–2816 [DOI] [PubMed] [Google Scholar]
- 3. Maron BJ: Hypertrophic cardiomyopathy: A systematic review. J Am Med Assoc 2002; 287: 1308–1320 [DOI] [PubMed] [Google Scholar]
- 4. McKenna WJ, Mogensen J, Elliott PM: Role of genotyping inriskfactor assessment for sudden death in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 2042–2048 [DOI] [PubMed] [Google Scholar]
- 5. Fananapazir L, Chang AC, Epstein SE, McAreavey D: Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992; 86: 730–740 [DOI] [PubMed] [Google Scholar]
- 6. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO III, Bonow RO, Maron BJ, Epstein SE: Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: A consecutive analysis in 155 patients. Circulation 1989; 80: 1259–1268 [DOI] [PubMed] [Google Scholar]
- 7. Kuroiwa M, Arai M, Ueno T, Takenaka T, Okamoto H, Hoka S: Perioperative cardiovascular complications in patients with hypertrophic cardiomyopathy. Masui 2003; 52: 733–739 [PubMed] [Google Scholar]
- 8. Haering JM, Comunale ME, Parker RA, Lowenstein E, Douglas PS, Krumholz HM, Manning WJ: Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology. 1996; 85: 254–259 [DOI] [PubMed] [Google Scholar]
- 9. Chang KH, Sano E, Saitoh Y, Hanaoka K: Anesthetic management of patients with hypertrophic obstructive cardiomyopathy undergoing non‐cardiac surgery. Masui 2004; 53: 934–942 [PubMed] [Google Scholar]
- 10. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froelich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542–553 [DOI] [PubMed] [Google Scholar]